Literature DB >> 24883458

Emergency department management of calcium-channel blocker, beta blocker, and digoxin toxicity.

Wesley Palatnick, Tomislav Jelic.   

Abstract

While it is relatively uncommon, an overdose of calcium-channel blockers, beta blockers, or digoxin has a significant morbidity and mortality rate, and its management can be complex. Digoxin toxicity can present with an acute overdose or as chronic toxicity while a patient is on therapeutic dosing, which has implications for diagnosis and management. While the patient's specific clinical presentation may depend on factors such as the time of exposure and the type of agent ingested, the differential diagnosis of the bradycardic and hypotensive patient is narrow, and toxicity from these agents must be considered. This review provides an evidence-based overview of the emergency department management of calcium-channel blocker overdose, beta blocker overdose, and digoxin toxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24883458

Source DB:  PubMed          Journal:  Emerg Med Pract        ISSN: 1524-1971


  3 in total

1.  Nifedipine toxicity is exacerbated by acetyl l-carnitine but alleviated by low-dose ketamine in zebrafish in vivo.

Authors:  Bonnie L Robinson; Qiang Gu; Volodymyr Tryndyak; Syed F Ali; Melanie Dumas; Jyotshna Kanungo
Journal:  J Appl Toxicol       Date:  2019-10-09       Impact factor: 3.628

2.  Extracorporeal Membrane Oxygenation in Drug Overdose: A Clinical Case Series.

Authors:  C Vignesh; Madhan Kumar; Ramesh Venkataraman; Senthilkumar Rajagopal; Nagarajan Ramakrishnan; Babu K Abraham
Journal:  Indian J Crit Care Med       Date:  2018-02

3.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.